Myovant Sciences Ltd. MYOV
26.98 +26.98
Day range unavailable
52-week range unavailable
Revenue & Expenses
Latest period ending Mar 31, 2022 · select a line to chart its full history
Income statement
| Fiscal year | FY 2022 Mar 31, 2022 | FY 2021 Mar 31, 2021 | FY 2020 Mar 31, 2020 | FY 2019 Mar 31, 2019 | FY 2018 Mar 31, 2018 |
|---|---|---|---|---|---|
| 230.97M | 59.32M | 0 | 0 | 0 | |
| 179.42M | 57.35M | 0 | 0 | 0 | |
| -187.35M | -260.78M | -274.89M | -264.83M | -141.06M | |
| -205.98M | -255.13M | -288.99M | -273.55M | -143.25M | |
| -2.22 | -2.83 | -3.37 | -4.09 | -2.41 |
Balance sheet
| Fiscal year | FY 2022 Mar 31, 2022 | FY 2021 Mar 31, 2021 | FY 2020 Mar 31, 2020 | FY 2019 Mar 31, 2019 | FY 2018 Mar 31, 2018 |
|---|---|---|---|---|---|
| 406.70M | 674.49M | 76.64M | 156.07M | 108.62M | |
| 520.01M | 725.03M | 105.93M | 172.98M | 119.10M | |
| 993.49M | 1.08B | 214.20M | 168.64M | 81.37M | |
| 367.89M | 369.70M | 126.21M | 99.38M | 43.62M | |
| -473.48M | -353.96M | -108.28M | 4.33M | 37.73M |
Cash flow
| Fiscal year | FY 2022 Mar 31, 2022 | FY 2021 Mar 31, 2021 | FY 2020 Mar 31, 2020 | FY 2019 Mar 31, 2019 | FY 2018 Mar 31, 2018 |
|---|---|---|---|---|---|
| -268.56M | 370.63M | -221.17M | -224.09M | -117.25M | |
| -18.02M | -9.21M | -3.94M | -1.24M | -604.00K | |
| 25.91M | 238.04M | 145.93M | 273.90M | 45.65M | |
| -974.00K | -1.77M | -1.10M | -1.24M | -604.00K | |
| -260.68M | 599.46M | -79.18M | 48.58M | -72.21M |